本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

众巢医学

1.19
-0.0100-0.83%
成交量:400.00
成交额:451.29
市值:3,000.57万
市盈率:-0.48
高:1.19
开:1.11
低:1.10
收:1.20
数据加载中...
2024/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/12

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/05/08

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/02

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

超过5%披露

General statement of acquisition of beneficial ownership
2020/02/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/14

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/14

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/12

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/12

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/06

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2020/01/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/01/10

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers